NCT02086461

Brief Summary

Delayed emptying of the gastric tube after esophagectomy is a frequent and durable problem. No treatment is currently available. It can be hypothesized that incomplete relaxation of the pyloric sphincter may be a significant contributing factor. Pneumatic dilatation may therefore be a potentially effective treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 13, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

January 3, 2019

Status Verified

January 1, 2019

Enrollment Period

6.6 years

First QC Date

March 11, 2014

Last Update Submit

January 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Symptoms suggestive of delayed gastric emptying

    Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation.

    3-12 months after treatment

Secondary Outcomes (2)

  • Quality of Life

    3-12 months after treatment.

  • Delayed gastric emptying

    3, 6 and 12 months after treatment.

Study Arms (2)

15 mm Pyloric balloon dilatation.

SHAM COMPARATOR

During fluoroscopic control the pneumatic balloon is positioned of the pyloric sphincter and maintained there during the entire dilatation.

Other: 15 mm pyloric balloon dilatation

Pneumatic pyloric dilatation.

ACTIVE COMPARATOR

Endoscopy and 15 mm balloon dilatation is completed according to the same principle as active comparator arm.

Device: Pneumatic pyloric dilatation

Interventions

Pneumatic pyloric dilatation.
15 mm Pyloric balloon dilatation.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Previous esophagectomy and gastric tube reconstruction.
  • Symptoms suggestive of delayed gastric emptying.
  • signed informed consent

You may not qualify if:

  • Signs of recurrent cancer disease
  • no symptoms suggestive of delayed gastric emptying.
  • unwillingness to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 14186, Sweden

Location

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jon Tsai, ass professor

    Karolinska University Hospital, Gastrocentrum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 11, 2014

First Posted

March 13, 2014

Study Start

May 1, 2014

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

January 3, 2019

Record last verified: 2019-01

Locations